Curated News
By: NewsRamp Editorial Staff
April 02, 2026
Sigyn Launches CTE Initiative for Former NFL Players Using Blood Purification Tech
TLDR
- Sigyn Therapeutics' CardioDialysis technology offers a potential competitive edge in treating CTE by clearing inflammatory molecules that drive disease progression in former NFL players.
- Sigyn Therapeutics' initiative evaluates CardioDialysis, which uses plasma separation and adsorption to continuously remove inflammatory molecules from the bloodstream, potentially slowing CTE progression.
- This initiative could improve the lives of former NFL players by developing treatments for CTE, reducing suffering from neurodegenerative diseases through innovative medical technologies.
- Chronic inflammation can keep the blood-brain barrier leaky for decades after head trauma, allowing harmful molecules to enter the brain and accelerate CTE development.
Impact - Why it Matters
This news matters because it addresses a critical health crisis among athletes, particularly former NFL players, who face disproportionately high risks of neurodegenerative diseases like CTE due to repetitive head trauma. The initiative represents a potential breakthrough in diagnosing and treating CTE in living patients, moving beyond post-mortem identification to active intervention. By targeting chronic inflammation—a key driver of CTE progression—Sigyn's approach could lead to earlier detection and more effective therapies, improving quality of life for athletes and potentially benefiting others with neuroinflammatory conditions. The use of blood purification technology like CardioDialysis offers a novel strategy to mitigate long-term brain damage, highlighting the intersection of sports medicine and advanced biotechnology in combating irreversible neurological disorders.
Summary
Sigyn Therapeutics, a medical technology company, has launched a groundbreaking initiative to evaluate emerging medical technologies for diagnosing and treating chronic traumatic encephalopathy (CTE) in former NFL players. The company, which develops CardioDialysis—a blood purification device that clears inflammatory molecules from the bloodstream—is responding to recent research showing that chronic inflammation drives CTE progression. This initiative will assess CardioDialysis's potential to reduce inflammatory molecules that cross the compromised blood-brain barrier, along with evaluating blood-based neuron-derived exosome assays for monitoring CTE and other therapies like a tau vaccine.
The initiative stems from Trinity College Dublin research revealing that chronic inflammation can keep the blood-brain barrier leaky for decades after athletes retire, allowing inflammatory molecules to trigger neuroinflammation and tau-protein accumulation—the hallmark of CTE. Former NFL players face significantly higher rates of neurodegenerative diseases like CTE, ALS, and Parkinson's, with repetitive head trauma initiating the condition and chronic inflammation fueling its progression. Sigyn's CEO, Jim Joyce, emphasized that this understanding opens new strategies for diagnosing and treating CTE in living patients through targeted inflammation control.
CardioDialysis, Sigyn's flagship technology, integrates plasma separation and therapeutic adsorption to continuously clear inflammatory cytokines and bacterial endotoxin from the bloodstream—key contributors to CTE progression. The device also addresses gut permeability issues exacerbated by inflammation, which can amplify neuroinflammation. Beyond CTE, Sigyn's pipeline includes therapies for sepsis, viral infections, and cardiovascular disease, with additional technologies like ImmunePrep and ChemoPrep for cancer treatment. To learn more about Sigyn Therapeutics, visit www.SigynTherapeutics.com, and view the original release on www.newmediawire.com for further details on this innovative approach to tackling neurodegenerative diseases in athletes.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Sigyn Launches CTE Initiative for Former NFL Players Using Blood Purification Tech
